Reading DNA Sequence and Epigenetic Modification State in 1 Molecule

Why It Matters

Linking sequence and epigenetic information on the same DNA fragment enables more precise biomarker discovery and improves diagnostic sensitivity for low‑abundance disease signals.

Key Takeaways

• Integrated sequencing reads DNA sequence and epigenetic marks simultaneously.
• Method distinguishes 5mC from 5hmC without losing base info.
• Hairpin duplex enables dual‑strand sequencing of same molecule.
• Potential for cell‑free cancer diagnostics via epigenetic signatures.
• Improves on deamination‑only approaches, preserving full genetic code.

Pulse Analysis

DNA methylation has long been a cornerstone of epigenetic research, yet conventional bisulfite sequencing blurs the line between 5‑methylcytosine and its oxidized counterpart, 5‑hydroxymethylcytosine. This ambiguity hampers efforts to decode cell‑type specific regulatory programs and to pinpoint disease‑associated epigenetic alterations. Recent advances in deaminase‑based methods attempted to separate these marks but sacrificed base‑pair fidelity, reducing the genetic alphabet to three letters and limiting downstream analyses.

The integrated sequencing approach introduced by Rahul Kohli’s lab resolves this dilemma by coupling a hairpin‑duplex strategy with selective chemical conversion. After copying each DNA fragment into a hairpin, analogs are installed on the newly synthesized strand to block deamination, while the original strand undergoes controlled deamination. Sequencing both strands yields a complete nucleotide readout alongside a binary map of 5mC versus 5hmC at each cytosine site. This dual‑readout preserves the full four‑letter code, eliminates the need for separate assays, and delivers single‑molecule resolution, a leap forward for epigenomic profiling.

Beyond basic research, the technology holds commercial promise, especially for liquid‑biopsy platforms that must detect rare tumor‑derived DNA amidst a sea of normal fragments. Epigenetic signatures, such as tissue‑specific 5mC/5hmC patterns, can augment mutation‑based detection, improving both sensitivity and specificity. As the market for non‑invasive cancer diagnostics expands, integrated sequencing could become a differentiator for biotech firms seeking to offer comprehensive genomic‑epigenomic panels, while also spurring new investigations into the functional roles of 5hmC in health and disease.